Tag: NASDAQ:BLU

November 14, 2019

BELLUS Health Reports Q3 Financial Results

The company also noted that the first patient was enrolled in its Phase 2 RELIEF Trial of BLU-5937 for chronic...
October 10, 2019

3 Top Pharma Stocks on the TSX and TSXV Year-to-Date

With three quarters of the year over, it's time to look back on the top-performing pharma stocks on the TSX...